Frontotemporal dementia: open trials in Australia

• NCT06823752

  A Dual Orexin Receptor Antagonist to Reduce Biomarkers of Neurodegeneration in Adults With Insomnia.

  Trial Treatment · Phase 2 · Woolcock Institute of Medical Research

  Woolcock Institute of Medical Research, Macquarie Park

  Registry updated 2026-09-18

• NCT07545473

  Retinal Hyperspectral Imaging in Neurodegenerative Diseases

  Trial Treatment · Center for Eye Research Australia

  The Centre for Eye Research Australia, Melbourne

  Registry updated 2026-04-22

• NCT05163288

  A Pivotal Study of N-Acetyl-L-Leucine on Niemann-Pick Disease Type C

  Trial Treatment · Phase 3 · IntraBio Inc

  The Royal Melbourne Hospital, Parkville

  Registry updated 2026-04-03

All Frontotemporal dementia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error